Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.38 Bil Enterprise Value: 31.47 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Q3 2023 Coloplast A/S Earnings Call Transcript

Aug 17, 2023 / 08:30AM GMT
Release Date Price: $115.07 (-4.11%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Coloplast 9 months 2022/'23 Earnings Release Conference Call. (Operator Instructions)

And I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you very much, operator and good morning. And welcome to our 9 Months '22/'23 Conference Call. I'm Kristian Villumsen, the CEO of Coloplast and I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions.

Please turn to Slide #3. We delivered 8% organic growth and our reported EBIT margin before special items of 28% in the third quarter. Return on invested capital after tax and before special items was 19% reflecting impact from the Atos Medical acquisition. We continue to broadly outgrow the market and more importantly, we continue to help a lot

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot